Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Fosrenol for Enhancing Dietary Protein Intake in Hypoalbuminemic Dialysis Patients (FrEDI) Study (FrEDI)

This study has been completed.
Sponsor:
Collaborators:
DaVita Dialysis
Shire
Information provided by (Responsible Party):
kamyar kalantar-zadeh, md phd mph, Los Angeles Biomedical Research Institute
ClinicalTrials.gov Identifier:
NCT01116947
First received: May 3, 2010
Last updated: February 27, 2012
Last verified: February 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2012
  Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)